Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Twist Bioscience Corporation (TWST) had Revenue of $96.06M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$96.06M
Net Income	$20.39M
Cost of Goods Sold	$44.76M
Gross Profit	$51.30M
Operating Expenses	$126.18M
Operating Income	$-30.12M
Non-Operating Income/Expense	$50.70M
Pre-Tax Income	$20.58M
Normalized Pre-Tax Income	$20.58M
Income after Taxes	$20.39M
Income from Continuous Operations	$20.39M
Consolidated Net Income/Loss	$20.39M
Normalized Income after Taxes	$20.39M
EBIT	$-30.12M
EBITDA	$-24.05M
Weighted-Average Shares Outstanding (Basic)	59.99M
Weighted-Average Shares Outstanding (Diluted)	61.16M
Earnings per Share (EPS) (Basic)	$0.34
Earnings per Share (EPS) (Diluted)	$0.33
Balance Sheet Financials
Current Assets	$339.78M
Property, Plant, and Equipment	$95.35M
Long-Term Assets	$303.83M
Total Assets	$643.61M
Current Liabilities	$87.07M
Long-Term Debt	$15.00M
Long-Term Liabilities	$78.34M
Total Liabilities	$165.41M
Common Equity	$478.20M
Tangible Shareholders Equity	$382.31M
Shareholders Equity	$478.20M
Common Shares Outstanding	60.17M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-35.81M
Cash Flow from Investing Activities	$-12.36M
Cash Flow from Financial Activities	$22.97M
Beginning Cash	$229.13M
End Cash	$203.91M
Increase/Decrease in Cash	$-25.23M
Stock-Based Compensation	$48.38M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.90
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.03
Debt to Equity Ratio	0.03
Gross Margin	53.40%
Operating Margin	-31.36%
EBIT Margin	-31.36%
EBITDA Margin	--
Pre-Tax Profit Margin	21.43%
Profit Margin	21.23%
Free Cash Flow	$-48.89M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.15
Inventory Turnover	1.73
Receiveable Turnover	1.93
Days Sales in Receivables	46.71
Return on Equity	4.26%
Return on Tangible Equity	5.33%
Return on Assets	3.17%
Return on Investments	4.13%
Book Value Per Share	$7.95
Free Cash Flow per Share	$-0.80
Operating Cash Flow per Share	$-0.59

Data from Zacks Investment Research, Inc.